Chronic Myelogenous Leukemia (CML) Has An Answer Now!
Another plant extract called Forskolin has been found to be helpful in inhibiting the growth of chronic myelogenous leukemia (
CML) cells in cultures and mice by up to 90 percent.// Forskolin is prepared from the root of the plant coleus forskohlii, a native of India that is used as an alternative remedy in other countries, and as an ornamental plant in the US.
CML, a malignant...
New Strategy for the Treatment of CML
Virginia Commonwealth University Massey Cancer Center researchers have identified an approach to enhance the activity of a new //anti-cancer agent that has already shown impressive efficacy in the treatment of chronic myelogenous leukemia. Chronic myelogenous leukemia, or
CML, is a cancer of the bone marrow caused by a specific genetic abnormality and is one of the more common forms of...
Independent Publication Confirms Growing Therapeutic Challenge of
T315I Mutation in Patients with CML, Notes ChemGenex
MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--May21, 2007 - ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ: CXSP) notesthe publication of new clinical data relevant to the developmentstrategy for Ceflatonin(R) (homoharringtonine). The paper "Targetedtherapy and the T315I mutation in Philadelphia-positive leukemias"by researchers Simona Soverini and colleagues at the University...
Independent Publication Confirms Growing Therapeutic Challenge of
T315I Mutation in Patients with CML, Notes ChemGenex
MELBOURNE, Australia, and MENLO PARK, CaliforniaU.S.A. (May 21, 2007): ChemGenex Pharmaceuticals (ASX: CXS, NASDAQ:CXSP) notes the publication of new clinical data relevant to thedevelopment strategy for Ceflatonin® (homoharringtonine). Thepaper "Targeted therapy and the T315I mutation inPhiladelphia-positive leukemias" by researchers Simona Soverini andcolleagues at...